134 related articles for article (PubMed ID: 19104811)
1. Tumor specific cytotoxicity of beta-glucosylceramide: structure-cytotoxicity relationship and anti-tumor activity in vivo.
Oku H; Li C; Shimatani M; Iwasaki H; Toda T; Okabe T; Watanabe H
Cancer Chemother Pharmacol; 2009 Aug; 64(3):485-96. PubMed ID: 19104811
[TBL] [Abstract][Full Text] [Related]
2. Tumor specific cytotoxicity of glucosylceramide.
Oku H; Wongtangtintharn S; Iwasaki H; Inafuku M; Shimatani M; Toda T
Cancer Chemother Pharmacol; 2007 Nov; 60(6):767-75. PubMed ID: 17256127
[TBL] [Abstract][Full Text] [Related]
3. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
4. Anticancer activity of glaucarubinone analogues.
Valeriote FA; Corbett TH; Grieco PA; Moher ED; Collins JL; Fleck TJ
Oncol Res; 1998; 10(4):201-8. PubMed ID: 9778691
[TBL] [Abstract][Full Text] [Related]
5. Beta-glucosylceramide administration (i.p.) activates natural killer T cells in vivo and prevents tumor metastasis in mice.
Inafuku M; Li C; Kanda Y; Kawamura T; Takeda K; Oku H; Watanabe H
Lipids; 2012 Jun; 47(6):581-91. PubMed ID: 22426862
[TBL] [Abstract][Full Text] [Related]
6. The metal-binding domain of IGFBP-3 selectively delivers therapeutic molecules into cancer cells.
Huq A; Singh B; Meeker T; Mascarenhas D
Anticancer Drugs; 2009 Jan; 20(1):21-31. PubMed ID: 19342998
[TBL] [Abstract][Full Text] [Related]
7. Gold (III) porphyrin complexes induce apoptosis and cell cycle arrest and inhibit tumor growth in colon cancer.
Tu S; Wai-Yin Sun R; Lin MC; Tao Cui J; Zou B; Gu Q; Kung HF; Che CM; Wong BC
Cancer; 2009 Oct; 115(19):4459-69. PubMed ID: 19572413
[TBL] [Abstract][Full Text] [Related]
8. A novel cancer therapy by skin delivery of indoleamine 2,3-dioxygenase siRNA.
Yen MC; Lin CC; Chen YL; Huang SS; Yang HJ; Chang CP; Lei HY; Lai MD
Clin Cancer Res; 2009 Jan; 15(2):641-9. PubMed ID: 19147770
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of Ru(III) complexes carrying beta-diketonato ligands in vitro and in vivo.
Arandjelovic SS; Bjelogrlic KS; Malesevic NN; Tesic LjZ; Radulovic SS
J BUON; 2009; 14(2):271-9. PubMed ID: 19650178
[TBL] [Abstract][Full Text] [Related]
10. A lactosylated steroid contributes in vivo therapeutic benefits in experimental models of mouse lymphoma and human glioblastoma.
Ingrassia L; Nshimyumukiza P; Dewelle J; Lefranc F; Wlodarczak L; Thomas S; Dielie G; Chiron C; Zedde C; Tisnès P; van Soest R; Braekman JC; Darro F; Kiss R
J Med Chem; 2006 Mar; 49(5):1800-7. PubMed ID: 16509595
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation.
Cullen R; Germanov E; Shimaoka T; Johnston B
J Immunol; 2009 Nov; 183(9):5807-15. PubMed ID: 19812206
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory and antitumor activity of triterpenoid fractions from the rhizomes of Astilbe chinensis.
Tu J; Sun HX; Ye YP
J Ethnopharmacol; 2008 Sep; 119(2):266-71. PubMed ID: 18692123
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effects of telomelysin for head and neck squamous cell carcinoma.
Fujita K; Kimura M; Kondo N; Sakakibara A; Sano D; Ishiguro Y; Tsukuda M
Oncol Rep; 2008 Dec; 20(6):1363-8. PubMed ID: 19020715
[TBL] [Abstract][Full Text] [Related]
14. Immune modulation and apoptosis induction: Two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera.
Malik F; Kumar A; Bhushan S; Mondhe DM; Pal HC; Sharma R; Khajuria A; Singh S; Singh G; Saxena AK; Suri KA; Qazi GN; Singh J
Eur J Cancer; 2009 May; 45(8):1494-509. PubMed ID: 19269163
[TBL] [Abstract][Full Text] [Related]
15. New tumoricidal semisynthetic ether phospholipid, plasmanyl-(N-acyl)ethanolamine (PNAE(s)) and enhancement of its tumoricidal activity by calcium ions.
Kára J; Konovalova AL; Krasnova MA; Liebl V; Bejsovcová L
Neoplasma; 1993; 40(4):213-7. PubMed ID: 8272147
[TBL] [Abstract][Full Text] [Related]
16. Sex dimorphism in antitumor response of chemotherapeutic drug cisplatin in a murine host-bearing a T-cell lymphoma.
Gupta V; Singh SM
Anticancer Drugs; 2008 Jul; 19(6):583-92. PubMed ID: 18525317
[TBL] [Abstract][Full Text] [Related]
17. Tumor-localized ligation of CD3 and CD28 with systemic regulatory T-cell depletion induces potent innate and adaptive antitumor responses.
Lee CH; Chiang YH; Chang SE; Chong CL; Cheng BM; Roffler SR
Clin Cancer Res; 2009 Apr; 15(8):2756-66. PubMed ID: 19318495
[TBL] [Abstract][Full Text] [Related]
18. Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast.
Kimura Y; Sumiyoshi M; Suzuki T; Sakanaka M
Anticancer Res; 2006; 26(6B):4131-41. PubMed ID: 17201124
[TBL] [Abstract][Full Text] [Related]
19. Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds.
Koch B; Baul TS; Chatterjee A
J Appl Toxicol; 2008 May; 28(4):430-8. PubMed ID: 17668440
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between sensitivity of tumor cells to chemotherapeutic agent in vivo and in vitro: experiment with mouse lymphoma cells].
Li CG; Li ML; Shu XH; Jia YJ; Liu YJ; Li M
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1576-8. PubMed ID: 17785116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
